Smiths Falls-based Canopy Growth will study the effects on cannabinoids on patients facing complications from concussions thanks to a new partnership with the NHL Alumni Association and Neeka Health Canada.
If successful, the partners hope the research could unlock new avenues to use cannabinoids in post-concussion treatment for athletes and everyday patients.
The local pot producer announced over the weekend it will work with its partners to determine how effective cannabis can be in addressing common post-concussion complications, such as depression, dementia or chronic traumatic encephalopathy (CTE).
OBJ360 (Sponsored)
Hard Rock Hotel & Casino Ottawa is the company’s new Canadian jewel
There’s a buzz of excitement at Hard Rock Hotel & Casino Ottawa as a $350-million transformation of the former Rideau Carleton Raceway nears completion. This high-energy entertainment destination will soon
Your next memorable getaway awaits in Whitewater Region
If you’re eager to immerse yourself in some quintessentially Canadian experiences, look no further than Whitewater Region in the County of Renfrew, in the Upper Ottawa Valley. It’s a four-season
The research will look to improve cognitive functions for the estimated 1.6 million to 3.8 million athletes that suffer concussions annually, 10 to 15 per cent of whom go on to develop symptoms of mental degradation. About 100 former NHL players will participate in the study.
Trials will begin this summer and are expected to last one year.
